MedTrace Logo

Hypertonic Saline Inhalation for Mycobacterium Avium Complex Pulmonary Disease

NCT05192057 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-06-26

No results posted yet for this study

Summary

The SALINE trial will investigate the effect of Hypertonic Saline inhalation plus best supportive care on burden of symptoms, clearance of mycobacteria and functional capacities in participants with Mycobacterium avium complex lung disease and compare the effect to treatment with best supportive care alone.

Conditions

  • Nontuberculous Mycobacterial Lung Disease
  • Mycobacterium Avium Complex

Interventions

DEVICE

Hypertonic Saline inhalation

Hypertonic Saline inhalation is thought to increase mucociliary clearance of the airways

Sponsors & Collaborators

  • Radboud University Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-20
Primary Completion
2026-10-01
Completion
2026-10-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05192057 on ClinicalTrials.gov